Clinical and Molecular HepatologyKCI 등재
Clinical and Molecular Hepatology
- 권호
- 85
- 논문
- 1,454
- 조회
- 1,813
27권 2호
2021.04 발행 · 논문 15편- 1Evaluation and Management of Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease조회 2
Donghee Kim, Aijaz Ahmed, Wijarnpreecha Karn, Elizabeth S. Aby·pp. 221–235
- 2Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects조회 2
Hideki Iwamoto, Takuji Torimura·pp. 236–245
- 3Current and future strategies for the treatment of chronic hepatitis C조회 2
Paul Y. Kwo, Omar Alshuwaykh·pp. 246–256
- 4From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?조회 2
Seung Up Kim, Yuri Cho, Soung Won Jeong, Jin-Woo Lee, Seong Hee Kang, Korean NAFLD Study Group·pp. 257–269
- 5A need for patient-centered care in managing patients with liver cirrhosis조회 2
Yoon Eileen L.·pp. 270–272
- 6Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact조회 2
Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip·pp. 273–277
- 7조회 1
- 8Another oral antiviral treatment, but still far away from hepatitis B virus cure조회 0
Tai-Chung Tseng·pp. 281–282
- 9Association between new-onset liver cirrhosis and suicide risk in South Korea: A nationwide cohort study조회 0
Byung Seok Lee, Seok Hyun Kim, Suk-Yong Jang, Woo Sun Rou, 은혁수·pp. 283–294
- 10Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B조회 2
이혜원, 한광협, 박준용, 김도영, 안상훈, 김승업, 김범경, Jae Seung Lee, Mi Young Jeon·pp. 295–304
- 11Direct comparison of biopsy techniques for hepatic malignancies조회 0
Jia-Horng Kao, Shang-Chin Huang, Ja-Der Liang, Shih-Jer Hsu, Tzu-Chan Hong, Hung-Chih Yang·pp. 305–312
- 12Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma조회 2
Ming-Lung Yu, Chia-Yen Dai, Chung-Feng Huang, Wan-Long Chuang, Jee-Fu Huang, Ming-Lun Yeh, Pei-Chien Tsai, Ching-Chih Lin, Ta-Wei Liu, Yi-Shan Tsai·pp. 313–328
- 13Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis조회 2
Ming-Hua Zheng, Jian Wu, Hong-Lei Ma, Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Chunming Ding·pp. 329–345
- 14Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial조회 2
Jae Young Jang, Won Kim, Byung Seok Lee, Ju Hyun Kim, Moon Young Kim, Dong Joon Kim, Kyun-Hwan Kim, Young Kul Jung, Hyung Joon Yim, Jin Mo Yang, Sang Hoon Ahn, Seung Kew Yoon, Young-Suk Lim, Hong Soo Kim, Jin-Woo Lee, Kwan Sik Lee, Yong Kyun Cho, Yoon Jun Kim, Do Seon Song, Young Oh Kweon, Gun Young Hong, Joo Hyun Sohn, Sung Jae Park, Wan Sik Lee, Kwang-Hyub Han, Soon Ho Um·pp. 346–359
- 15Clinical and serological prognostic markers in primary biliary cholangitis조회 2
Wilhelmi Markus·pp. 360–361